A Phase I Study of TQ-B3456 on Tolerance and Pharmacokinetics

Clinical trial NCT03754244 · TERMINATED

Trial details

NCT number: NCT03754244
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2020-09-24
Primary completion: 2022-02-28
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.